Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta

Journal of Vascular Surgery

Volumn 25, Issue 1, 1997, Pages 157-164

  Shireman, P K ^a   McCarthy, W J ^a   Pearce, W H ^a   Shively, V P ^a   Cipollone, M ^a   Kwaan, H C ^a  

^a Cardiology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; RNA; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ABDOMINAL AORTA; ADULT; AGED; AORTA ANEURYSM; ARTERIOSCLEROSIS; ARTICLE; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RNA ANALYSIS; RNA SYNTHESIS;

EID: 0031043854     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(97)70333-1     Document Type: Article

References (34)

1. J Jean-Claude KM Newman H Li AK Gregory MD. Tilson Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms Surgery 116 1994 472 478
2. G Murphy S Atkinson R Ward J Gavrilovic JJ. Reynolds The role of plasminogen activators in the regulation of connective tissue metalloproteinases Ann N Y Acad Sci 667 1992 1 12
3. N Vine JT. Powell Metalloproteinases in degenerative aortic disease Clin Sci 81 1991 233 239
4. JM Reilly GA Sicard CL. Lucore Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease J Vasc Surg 19 1994 865 872
5. P Chomczynski N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
6. PK Shireman WJ McCarthy WH Pearce BK Patterson VP Shively M Cipollone Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta J Vasc Surg 23 1996 810 818
7. MS Pepper J-D Vassalli R Montesano L. Orci Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells J Cell Biol 105 1987 2535 2541
8. M. Mayor Biochemical and biological aspects of the plasminogen activation system Clin Biochem 23 1990 197 211
9. TL Moser TN Young GC Rodriguez SV Pizzo RC Bast MS. Stack Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma Int J Cancer 56 1994 552 559
10. TN Young GC Rodriquez TL Moser RC Bast SV Pizzo MS. Stack Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium Am J Obstet Gynecol 170 1994 1285 1296
11. C Bouchet F Spyratos PM Martin K Hacene A Gentile J. Oglobine Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas Br J Cancer 69 1994 398 405
12. AE Koch GK Haines RJ Rizzo Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune mediated response Am J Pathol 137 1990 1198 1213
13. J Schneiderman GM Bordin I Engelberg Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall J Clin Invest 96 1995 639 645
14. EG Levin DJ. Loskutoff Regulation of plasminogen activator production by cultured endothelial cells Ann N Y Acad Sci 401 1982 184 194
15. AW Clowes MM Clowes YPT Au MA Reidy D. Belin Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery Circ Res 67 1990 61 67
16. KJ Stacey LF Fowles MS Colman MG Ostrowski DA. Hume Regulation of urokinase type plasminogen activator gene transcription by macrophage stimulating factor Mol Cell Biol 15 1995 3430 3441
17. M Jorgensen V. Bonnevie-Nielsen Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis Br J Haematol 65 1987 175 180
18. A Hamsten B Wiman U De Faire M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1985 1557 1563
19. FB Smith AJ Lee A Rumley FGR Fowkes GDO. Lowe Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease Atherosclerosis 115 1995 35 43
20. N Tromholt SJ Jorgenson B Hesse MS. Hansen In vivo demonstration of focal fibrinolytic activity in abdominal aortic aneurysms Eur J Vasc Surg 7 1993 675 679
21. JM Herbert I Lamarche V Prabonnaud F Dol T. Gauthier Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells J Biol Chem 269 1994 3076 3080
22. J Schneiderman MS Sawdey MR Keeton Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries Proc Natl Acad Sci U S A 89 1992 6998 7002
23. J Wojta M Gallicchio H Zoellner Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells Thromb Haemost 70 1993 469 474
24. EG Levin U Marzec J Anderson LA. Harker Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells J Clin Invest 74 1984 1988 1995
25. Y Hashimoto A Kobayashi N Yamazaki Y Sugawara Y Takada A. Takada Relationship between age and plasma tPA, PA-inhibitor, and PA activity Thromb Res 46 1987 625 633
26. MF Aillaud F Pignol MC Alessi Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C, and in erythrocyte sedimentation rate with age Thromb Haemost 55 1986 330 332
27. M Eliasson PE Evrin D. Lundblad Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden Monica Study J Clin Epidemiol 47 1994 513 524
28. M Margalione G Di Minno E Grandone Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke Arterioscler Thromb Vasc Biol 14 1994 1741 1745
29. M Ranby N Bergsdorf T Nilsson G Mellbring B Winblad G. Bucht Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunsorbent assay Clin Chem 32/12 1986 2160 2165
30. C Krishnamurti DB Tang CF Barr BM. Alving Plasminogen activator and plasminogen activator inhibitor activities in a reference population Am J Clin Pathol 89 1988 747 752
31. J Yamashita M Ogawa K Inada Breast cancer prognosis is poor when total plasminogen activity is low 67 1993 374 378
32. H Pedersen J Grondahl-Hansen D Francis Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma Cancer Res 54 1994 120 123
33. PJ Declerck M De Mol MC Alessi Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma J Biol Chem 263 1988 15454 15461
34. DJ Loskutoff BE Van Aken D. Seiffert Abnormalities in the fibrinolytic system of the vascular wall associated with atherosclerosis Ann NY Acad Sci 748 1995 177 183